Drugs Made In America Acquisition Corp. (DMAAR) Prepaid Assets (2024 - 2026)

Drugs Made In America Acquisition (DMAAR) has reported Prepaid Assets for 3 consecutive years, with $48904.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Prepaid Assets changed 0.0% year-over-year to $48904.0; the trailing twelve-month figure through Jun 2026 stood at $48904.0 (changed 0.0% YoY), and the FY2025 full-year result was $6054.0, up 66.32% from the prior year.
• Prepaid Assets advanced to $48904.0 in Q2 2026 per DMAAR's latest filing, from $6054.0 in the prior quarter.
• Across five years, Prepaid Assets topped out at $70096.0 in Q1 2025 and bottomed at $3640.0 in Q4 2024.
• Historically, Prepaid Assets has averaged $34179.5 across 3 years, with a median of $38191.5 in 2025.
• The sharpest annual moves came in 2025 and 2026: Prepaid Assets soared 66.32% in 2025, then changed 0.0% in 2026.
• Over 3 years, Prepaid Assets stood at $3640.0 in 2024, then soared by 66.32% to $6054.0 in 2025, then jumped by 707.8% to $48904.0 in 2026.
• According to Business Quant data, Prepaid Assets over the past three periods registered $48904.0, $6054.0, and $27479.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.